Canada's pharmacy consolidators in 2026: who they are and how they buy

Canada’s pharmacy consolidators in 2026 are a short list. The most active buyer of independent stores is Neighbourly Pharmacy, owned by Persistence Capital Partners, with 342 pharmacies as of 6 October 2026. Behind it are a newer listed roll-up, PharmaCorp Rx, and the large operators that buy selectively: Shoppers Drug Mart (Loblaw), Sobeys (Empire), the Pattison Food Group, Metro, Rexall (Birch Hill Equity Partners), Calgary Co-op through Care Pharmacies, and CareRx in long-term care. McKesson, Pharmasave, PharmaChoice, Wholehealth and Pharmacy Brands Canada are banners. They sign owners up rather than buy them.

Our guide to who buys pharmacies in Canada compares the five routes to a sale. This article goes one level deeper, company by company: who owns each buyer, how big it is (with an “as of” date), what it buys, how it usually structures a deal, and what happens to the name and the staff afterwards. At PharmacyBroker.ca we work with the acquisition and business development teams at most of these companies and present pharmacies to them, so this is written to be fair to all of them. Every fact below comes from a public source we checked in October 2026. Where something is not public, we say so.

Canada’s pharmacy consolidators at a glance

The store counts come from different dates and sources, so read them as approximate. None of these companies publishes the multiples it pays.

The main acquirers, one by one

Neighbourly Pharmacy

Neighbourly is the buyer most owners mean when they say “consolidator”. It was listed on the TSX until Persistence Capital Partners (PCP), already its controlling shareholder, took it private. The deal closed on 20 March 2024 at $18.50 a share in cash, plus a contingent value right worth $0.61 a share that pays only if the business hits a fiscal 2026 earnings target (ConnectCRE). Brookfield provided up to $320 million of structured equity, and Scotiabank and RBC committed a $600 million credit facility.

Neighbourly had 294 pharmacies at that closing. It added 33 in September 2025, “including several remote and northern communities” (ConnectCRE), seven more in the Prairies and Central Canada in August 2026, and ten more on 6 October 2026, for a network of 342 (Retail Insider). Its announcements always say “in multiple transactions”, so it is buying stores one or a few at a time, not in big blocks. It does not publish a provincial breakdown. In our own BC directory it held 68 BC pharmacies under its companies at 7 October 2026.

Its own website says it operates “under these established names to preserve local identity, maintain trusted relationships, and ensure continuity for patients and teams”, and it has a “Selling Your Pharmacy?” contact for owners (Neighbourly). Its CEO describes it as “the partner of choice for independent pharmacy owners seeking succession solutions.” Whether a particular deal is an asset or a share purchase, and whether the owner stays on, is not published. Expect it to be negotiated store by store.

Neighbourly also shows how private equity platforms change hands. It bought Rubicon Pharmacies for $435 million in 2022 (PE Hub). Rubicon itself was built by TorQuest, a private equity firm, which in 2018 merged Rubicon’s 67 Prairie stores with Amenity Health Care’s 34 Western stores (RENX).

PharmaCorp Rx

PharmaCorp is a Saskatoon company listed on the TSX Venture Exchange. It is small next to Neighbourly but publishes more about how it buys, because it reports each deal.

Its 2026 deals. In July 2026 it closed the purchase of all the shares of eight PharmaChoice stores in Eastern Canada for about $24.2 million, taking it from six to 14 stores (press release). On 31 July it closed an Ontario PharmaChoice store for about $8.1 million (Newsfile). On 18 August it reported a 16th store, in Western Canada, for about $2.47 million, plus signed agreements for another Western store (about $1.3 million) and for the prescription files of an I.D.A. store (about $475,000) that would move to a nearby PharmaChoice location (Stockwatch). An early October 2026 headline reports two more closings for about $1.8 million combined. These prices include whatever inventory and real estate came with each deal, so they cannot be turned into a multiple.

Its model. PharmaCorp says all locations “will continue to be operated by their existing managing pharmacists” and describes itself as “empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners.” It rebrands non-bannered stores under PharmaChoice but has kept other banners in some deals: a Remedy’sRx store under letter of intent was to keep its location and banner. On price, management says only that it aims for “a disciplined weighted average EBITDA multiple across transactions” (Q3 2025 results).

The CIBC co-ownership program. In August 2025 PharmaCorp announced credit facilities with CIBC, including a separate $5 million facility for a Pharmacist Co-Ownership Program. It lends pharmacists up to 100 percent of their equity investment in the PharmaCorp pharmacy where they work, with repayment terms of up to 15 years (SFNet copy of the release). The maximum ownership share is not published. For a seller with a strong manager, this matters: your manager may be able to become a part owner of the store after you leave.

Shoppers Drug Mart and Loblaw

Shoppers is the largest pharmacy network in the country: 1,352 associate-owned Shoppers Drug Mart and Pharmaprix stores as at 3 January 2026, according to Loblaw’s annual information form. Loblaw defines an associate as “a pharmacist-owner of a corporation that is licensed to operate a retail drug store at a specific location” and notes that associates “are subject to franchise legislation” (Loblaw AIF 2026). Loblaw also owns MediSystem, its long-term care pharmacy business.

Shoppers grows mainly by opening stores and clinics, and the AIF does not mention buying independents. But it does buy them: its seller page says “We have helped over 500 independent pharmacy owners confidently sell their pharmacies” and lists acquisition directors for Ontario and Atlantic Canada, Quebec, BC and Saskatchewan, and Alberta and Manitoba (Shoppers / Pharmaprix). After a sale the store becomes a Shoppers, run by an associate under licence. The name, systems and front shop change, and in our experience the pharmacy team usually carries on.

Sobeys and Empire

Empire Company owns Sobeys and its banners: Sobeys, Safeway, Thrifty Foods, FreshCo, Foodland, IGA, Farm Boy and Lawtons Drugs, and it holds a stake in Longo’s. Empire does not publish a total pharmacy count in the documents we opened. Lawtons had 76 stores in the four Atlantic provinces in April 2022 (Chain Drug Review).

Empire is buying. On 18 August 2026 it agreed to acquire nine Morelli’s pharmacies located inside Longo’s grocery stores in the GTA and Hamilton. The price was not disclosed. Each will become a Longo’s Pharmacy and join “Sobeys National Pharmacy operations”, subject to Ontario College of Pharmacists approval, with closing expected in the second quarter of Empire’s fiscal 2027 (Empire release). Sobeys also buys single stores and files to serve from its in-store pharmacies, as our buyer routes guide describes.

Pattison Food Group (and why London Drugs is separate)

The Pattison Food Group, part of the Jim Pattison Group, runs pharmacies under the Save-On-Foods, Urban Fare and PriceSmart Foods banners, “more than 150 pharmacies serving over 60 communities across Western Canada” according to its BC Pharmacy Association partner listing (BCPhA, undated, read October 2026). It is the second largest operator in BC in our directory. Its typical interest is a pharmacy, or a set of prescription files, near a store it already runs.

London Drugs is often lumped in with Pattison, but it is owned by H.Y. Louie Co., which has held it since 1976. It had 78 stores in February 2026: 50 in BC, 21 in Alberta, 5 in Saskatchewan and 2 in Manitoba (Wikipedia). We found no public record of it buying independent pharmacies.

Metro, Jean Coutu and Brunet, and the Quebec rule

Metro had 638 pharmacies at the end of its fiscal year on 27 September 2025: 419 Jean Coutu franchised stores (in Quebec, New Brunswick and Ontario), 141 Brunet-family stores “held by pharmacist-owners”, and 78 company-run Metro Pharmacy and Food Basics Pharmacy locations in Ontario (Metro annual report 2025).

Quebec works differently from the rest of Canada. Section 27 of the Pharmacy Act says only a pharmacist, a partnership of pharmacists, a company whose shares and directors are all pharmacists, or a non-profit whose founders, directors and members are all pharmacists may own a pharmacy (Pharmacy Act, CQLR c P-10). A corporate consolidator cannot simply buy a Quebec store. In Quebec, Metro is franchisor and distributor rather than owner, and the real buyer of a Quebec pharmacy is always a pharmacist, often supported by a banner such as Jean Coutu, Brunet, Familiprix, Uniprix or Proxim.

Rexall under Birch Hill

McKesson sold Rexall and Well.ca to Birch Hill Equity Partners, a Toronto private equity firm, in a deal that closed on 30 December 2024 (Business Wire). Rexall had 385 pharmacies and about 8,000 employees, and the terms were not disclosed (Chain Drug Review). Birch Hill said it was “committed to maintaining and investing in reliable, accessible healthcare services”, and McKesson was to stay the wholesale supplier (ConnectCRE). We found no public announcement of Rexall buying independents since the sale. Rexall stores are corporate owned, so a sale to Rexall is a sale to the company.

Calgary Co-op and Care Pharmacies

In January 2024 a Calgary Co-op subsidiary agreed to become majority owner of Care Pharmacies, a Vaughan, Ontario group with 56 pharmacies in five provinces at the time. Care’s CEO and leadership team stayed, and Care continues “to operate as a separate entity” (Calgary Co-op). Calgary Co-op also ran 24 of its own pharmacies and two Beacon Pharmacy locations then, and its CEO said acquisitions would continue but “It’s not all about acquisition” (Retail Insider).

CareRx and long-term care

CareRx (TSX: CRRX) describes itself as “Canada’s leading provider of pharmacy services to seniors living and other congregate care communities.” In Q2 2026 it served an average of 91,719 beds, and its recent growth came from contracts, including a national contract won “through a competitive process, without acquisition” (CareRx Q2 2026). For a long-term care pharmacy the buyer pool and the valuation drivers are different: contract term, assignability and concentration come first. Our long-term care valuation guide covers this.

Banners that sign owners up rather than buy them

These groups are often called consolidators, but their model is to recruit owners, not to buy stores.

• McKesson Canada is a distributor (it says it delivers about a third of medications to Canadians) and the owner of six banners: Guardian, I.D.A., Remedy’sRx, The Medicine Shoppe, Uniprix and Proxim (McKesson Canada). Chain Drug Review reported over 2,700 locations in April 2026 (CDR). Its banner stores are targets for buyers, and its business development teams often introduce pharmacist buyers.
• Pharmasave and PharmaChoice are owned by their members. An Ontario Securities Commission decision (19 January 2023) confirms Pharmasave’s franchise agreement includes “further restrictions on the transfer of shares and right of first refusal” (OSC). Whatever your banner, read its agreement early.
• Wholehealth Pharmacy Partners says “each of our owners also have a piece of equity in the banner” and claims over 300 locations in eight provinces on its homepage, while its own site description says over 200 (Wholehealth).
• Pharmacy Brands Canada passed 300 locations in September 2026 and says it supports owners “with no banner fees” through three models, aiming to help them succeed “while keeping control of their businesses” (Newswire). Its ownership is not public.

Costco and Walmart run pharmacies inside their own stores. We found no public record of either buying independent pharmacies, so they are not part of this market for most sellers.

Private equity in pharmacy, and what it means for sellers

Two of the biggest pharmacy owners in Canada are now private equity backed: Neighbourly (PCP, with Brookfield) and Rexall (Birch Hill). PharmaCorp is public, but it raises money the same way, through share offerings and bank debt. The Rubicon story shows the cycle: built by one fund, sold to a larger platform four years later.

What this means in practice:

They are steady, organized buyers. A fund-backed platform has a deal team, lenders and a standard purchase agreement, and it buys every year.

They are disciplined on price. Every deal has to fit a return target. PharmaCorp says so openly. That is not a criticism. It means a fund-backed buyer will pay well for a store that fits and walk away from one that does not.

The owner of your old store may change again. If you stay on as manager, take equity, or accept part of the price later through an earnout or holdback, you are tied to a business that may itself be sold. The Neighbourly take-private paid shareholders part of their price through a value right linked to a future earnings target, a public example of contingent pay. Read any earnout or equity terms with that in mind.

What consolidators look for and what they pay for

No consolidator publishes the multiple it pays, and the reported figures for the Neighbourly take-private do not agree with each other, so we do not quote one. Our house view is that most Canadian community pharmacies sell for about 4 to 6 times normalized EBITDA plus inventory at cost, and our valuation guide explains how a store lands within that range. Where a consolidator pays more, it is for strategic value, not because it uses a different formula.

From the public statements and our own work with these teams, they look for:

• Stable or growing prescriptions and clean, normalized financials.
• A lease with years left, or premises they can secure.
• A manager who will stay. PharmaCorp’s whole model rests on this, and Neighbourly’s continuity message does too.
• Network fit. A store near others they own, in a region they want to grow, or in a rural or northern community where the pharmacy is the main health access point.
• Low owner dependence. A store that runs without the owner at the counter every day is worth more to a buyer that will not supply an owner.

A store that misses on these may still sell well, often to an independent pharmacist looking at a pharmacy for sale in their own area, but a consolidator may pass. In the pharmacies we have listed or sold since 2025, asking prices have run from under $500,000 for small or older stores to about $4 million for a high-volume automated store, and the buyer types interested were different at each end.

What changes after the sale

Name. Neighbourly and Care say they keep the existing names. PharmaCorp keeps some banners and moves non-bannered stores to PharmaChoice. Shoppers, Sobeys and grocers convert the store to their own brand, as the Morelli’s stores becoming Longo’s Pharmacy shows.

Staff. Consolidators usually want the team, because the local relationships are what they are buying. In a share sale the employer company stays the same. In an asset sale, the buyer offers employment and your province’s employment law sets the rules on notice and service. Our asset sale vs share sale guide explains the difference.

Patients. In a going-concern sale, patients see little change at the counter. In a file purchase, the records move to the buyer’s nearby pharmacy and your location closes, as in PharmaCorp’s I.D.A. file deal. Plan how and when patients are told.

Systems. Expect a change in wholesaler, dispensing software, purchasing and front-shop programs to the buyer’s standard over time. Neighbourly describes managing everything “from sourcing through post-closing integration.” The details are rarely public, so ask before you sign.

One offer or a competitive process

Most sales to consolidators start with a phone call to the owner, not with a listed pharmacy for sale. That call is a real opportunity, and these teams are professional to deal with. The question is not whether to talk to them, but whether to decide on one offer alone.

When one offer makes sense. The store fits one buyer far better than anyone else, speed and certainty matter more than the last dollar, or you already trust the buyer. Taking a direct offer knowingly is a legitimate choice.

What a competitive process adds. The same pharmacy is presented, under NDA and on the same information, to the buyer types that fit it: consolidators, chains, grocers, banner-backed pharmacists and regional groups. Offers can then be compared on price, structure, deposit, exclusivity period, transition and how much is paid at closing. Our letter of intent guide shows what to compare, and the confidentiality guide explains how to share information with a buyer who may also be a competitor down the street.

This is where we sit. We present each pharmacy for sale to the business development teams at Shoppers, Neighbourly, Sobeys, the Jim Pattison Group, Metro and Jean Coutu, McKesson, Pharmasave, CareRx and Calgary Co-op, and to the independent pharmacists and groups on our buyer list, at the same time. The buyers who fit make offers, and the owner chooses. A process usually runs 6 to 12 months from decision to closing, as our selling timeline sets out.

Preparing before the first call

Whether you sell direct or run a process, a few things put you in a stronger position before any consolidator calls:

1. Know your number. Run the valuation calculator, which takes six inputs and no contact details.
2. Normalize your financials and document every add-back, using our EBITDA guide. The buyer’s team will do this on its terms if you have not.
3. Check your contracts. Read your banner agreement for consent rights or a right of first refusal, and check the years left on your lease.
4. Talk to your manager. If a consolidator will want them to stay, or PharmaCorp-style equity is on the table, their plans affect your price.
5. Decide what matters to you. Price, the store’s name, your staff’s future, your own role after closing. Write it down before the first meeting.
6. Get advice early. Have your lawyer and accountant look at structure and tax before you sign a letter of intent, including the 2026 lifetime capital gains exemption of $1,275,000 if your shares qualify.

If a consolidator has already called, talk to us before you reply. The conversation is confidential, and knowing what the other buyers would pay costs nothing.